ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,562Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 198

$485K Total Retail Price of All Prescriptions

Rank: 64 out of 198

465 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 465 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 11,579 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 743 697 1 5
LEVOTHYROXINE SODIUM 741 673 2 1
WARFARIN SODIUM 384 366 3 7
SIMVASTATIN 333 323 4 2
LISINOPRIL 310 310 5 6
METOPROLOL SUCCINATE 303 297 6 11
METOPROLOL TARTRATE 276 271 7 10
POTASSIUM CHLORIDE 251 225 8 9
OMEPRAZOLE 222 174 9 3
AMLODIPINE BESYLATE 211 203 10 4
HYDROCODONE-ACETAMINOPHEN 203 195 S3 11 8
GLIMEPIRIDE 198 175 12 35
CIPROFLOXACIN HCL 170 159 13 55
METFORMIN HCL 163 145 14 13
CARVEDILOL 160 148 15 24
ALLOPURINOL 146 139 16 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 140 17 38
IBUPROFEN 142 136 18 124
GABAPENTIN 138 90 19 14
ATORVASTATIN CALCIUM 135 133 20 12
CEPHALEXIN 135 132 20 108
NAMENDA 131 131 22 33
ATENOLOL 129 129 23 17
MONOJECT INSULIN SAFETY SYRNG 126 122 24 118
SPIRONOLACTONE 124 119 25 37
LOSARTAN POTASSIUM 123 105 26 18
PREDNISONE 118 106 27 29
HYDROCHLOROTHIAZIDE 111 110 28 16
DIGOXIN 110 80 29 43
CITALOPRAM HBR 105 80 30 20
CELEBREX 100 99 31 59
PRAVASTATIN SODIUM 99 99 32 19
PANTOPRAZOLE SODIUM 99 98 32 31
TRAMADOL HCL 95 88 34 15
PAROXETINE HCL 92 89 35 65
OXYBUTYNIN CHLORIDE ER 88 71 36 109
CLOPIDOGREL 86 68 37 42
PROPRANOLOL HCL 85 85 38 92
CLONIDINE HCL 85 82 38 52
RANITIDINE HCL 84 84 40 54
ESCITALOPRAM OXALATE 80 73 41 53
PLAVIX 80 66 41 66
AMITRIPTYLINE HCL 75 65 R 43 69
ADVAIR DISKUS 73 73 44 47
ZOLPIDEM TARTRATE 71 64 45 22
LANSOPRAZOLE 69 53 46 166
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 59 47 90
FENOFIBRATE 65 65 48 61
DIOVAN 64 62 49 34
TRIAMTERENE-HCTZ 58 58 50 32
ENALAPRIL MALEATE 58 47 50 51
INSULIN SYRINGE 58 0 50 95
SUCRALFATE 58 58 50 165
LOSARTAN-HYDROCHLOROTHIAZIDE 53 50 54 49
LANTUS 52 40 55 46
TAMSULOSIN HCL 51 51 56 27
CYCLOBENZAPRINE HCL 50 37 R 57 67
FAMOTIDINE 50 39 57 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.